Citeline, Biomedtracker: see the drug development process th...
Catch up on any missed COVID-19 24 hour webinar sessions
Informa's Japanese office, a British company that operates Pharma Intelligence, held a special free seminar in Tokyo on May 17, 2017. Tijana Ignjatovik, Lead Analyst of Datamonitor Healthcare, and Scrip's Editor-In-Chief, Ian Haydock, gave a lecture on the theme "Pharmaceutical companys' new challenge to medical, economic evaluation." Professionals from various fields including pharmaceutical companies and chemical companies, as well as academia-industry, media stakeholders, financial industry, etc., participated.
Datamonitor Healthcare: data analysis and insight, Pink Shee...
By Tara Hansen
The FDA Oncology Center of Excellence’s ‘industry-wide evaluation’ of accelerated approvals has already led to withdrawals of four PD-1/PD-L1 inhibitor indications, with the Oncologic Drugs Advisory Committee set to review another six in late April. Over the next two years, an additional five indications may be up for review.
Datamonitor Healthcare: data analysis and insight
Biopharma’s accomplishments in tackling the global COVID-19 pandemic, unlike advances within oncology such as cell therapies and checkpoint inhibitors, or functional cures for HIV and hepatitis C, have captured the public’s imagination.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: